KR102517287B1 - 조혈 줄기 세포 이식을 받는 환자를 치료하기 위한 분변 미생물총 - Google Patents

조혈 줄기 세포 이식을 받는 환자를 치료하기 위한 분변 미생물총 Download PDF

Info

Publication number
KR102517287B1
KR102517287B1 KR1020197024970A KR20197024970A KR102517287B1 KR 102517287 B1 KR102517287 B1 KR 102517287B1 KR 1020197024970 A KR1020197024970 A KR 1020197024970A KR 20197024970 A KR20197024970 A KR 20197024970A KR 102517287 B1 KR102517287 B1 KR 102517287B1
Authority
KR
South Korea
Prior art keywords
fecal
hsc
transplantation
pharmaceutical composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197024970A
Other languages
English (en)
Korean (ko)
Other versions
KR20190130563A (ko
Inventor
모하마드 모티
해리 소콜
Original Assignee
소르본 유니베르시테
상뜨르 나쇼날 드 라 러쉐르쉬 샹띠피끄
인스티튜트 내셔널 드 라 싼테 에 드 라 리셰르셰 메디칼르 (인 썸)
아시스땅스 퍼블리끄-오삐또 드 빠리
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59325347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102517287(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 소르본 유니베르시테, 상뜨르 나쇼날 드 라 러쉐르쉬 샹띠피끄, 인스티튜트 내셔널 드 라 싼테 에 드 라 리셰르셰 메디칼르 (인 썸), 아시스땅스 퍼블리끄-오삐또 드 빠리 filed Critical 소르본 유니베르시테
Publication of KR20190130563A publication Critical patent/KR20190130563A/ko
Application granted granted Critical
Publication of KR102517287B1 publication Critical patent/KR102517287B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020197024970A 2017-01-26 2018-01-26 조혈 줄기 세포 이식을 받는 환자를 치료하기 위한 분변 미생물총 Active KR102517287B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1750629A FR3062063B1 (fr) 2017-01-26 2017-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
FR1750629 2017-01-26
PCT/EP2018/051941 WO2018138251A1 (fr) 2017-01-26 2018-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques

Publications (2)

Publication Number Publication Date
KR20190130563A KR20190130563A (ko) 2019-11-22
KR102517287B1 true KR102517287B1 (ko) 2023-03-31

Family

ID=59325347

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197024970A Active KR102517287B1 (ko) 2017-01-26 2018-01-26 조혈 줄기 세포 이식을 받는 환자를 치료하기 위한 분변 미생물총

Country Status (20)

Country Link
US (1) US20200188450A1 (enExample)
EP (1) EP3573631B1 (enExample)
JP (1) JP7527109B2 (enExample)
KR (1) KR102517287B1 (enExample)
CN (1) CN110520141A (enExample)
AU (1) AU2018212530B2 (enExample)
CA (1) CA3051807C (enExample)
DK (1) DK3573631T3 (enExample)
ES (1) ES2937965T3 (enExample)
FI (1) FI3573631T3 (enExample)
FR (1) FR3062063B1 (enExample)
HR (1) HRP20230122T1 (enExample)
HU (1) HUE061155T2 (enExample)
IL (1) IL268237B (enExample)
LT (1) LT3573631T (enExample)
PL (1) PL3573631T3 (enExample)
PT (1) PT3573631T (enExample)
RS (1) RS63978B1 (enExample)
SI (1) SI3573631T1 (enExample)
WO (1) WO2018138251A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3072032A1 (en) * 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US20220023419A1 (en) * 2018-11-28 2022-01-27 The Council Of The Queensland Institute Of Medical Research Inhibiting inflammation
CN112375705A (zh) * 2020-11-12 2021-02-19 安徽燕婉健康科技有限公司 一种替代天然菌群的肠壁移植优势菌的制备方法及其应用
EP4386090A1 (en) * 2022-12-12 2024-06-19 Assistance Publique - Hôpitaux De Paris Method for determining and improving the potential efficacy of anticancer treatment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160143961A1 (en) * 2014-11-25 2016-05-26 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649719B1 (fr) * 1989-07-17 1993-08-27 Cerbio Sa Procede de protection et de conservation de micro-organismes notamment de bacteries
CN103561752B (zh) * 2011-03-09 2016-04-20 明尼苏达大学评议会 用于移植结肠微生物群的组合物和方法
JP2016501852A (ja) * 2012-11-26 2016-01-21 トーマス・ジュリアス・ボロディ 糞便微生物叢の回復のための組成物、ならびにそれらを作製および使用する方法
US10046030B2 (en) * 2014-10-07 2018-08-14 University Of Virginia Patent Foundation Compositions and methods for preventing and treating infection
AU2015353465B2 (en) * 2014-11-25 2021-07-29 Memorial Sloan-Kettering Cancer Center Intestinal microbiota and GVHD
FR3035328B1 (fr) * 2015-04-24 2019-08-23 Maat Pharma Procede de preparation d'un echantillon de microbiote fecal
JP6408092B2 (ja) * 2016-08-29 2018-10-17 国立大学法人 東京大学 糞便微生物叢を含む組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160143961A1 (en) * 2014-11-25 2016-05-26 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease

Also Published As

Publication number Publication date
CA3051807A1 (fr) 2018-08-02
LT3573631T (lt) 2023-03-10
FR3062063B1 (fr) 2019-04-19
SI3573631T1 (sl) 2023-09-29
DK3573631T3 (da) 2023-01-30
AU2018212530A1 (en) 2019-09-05
JP7527109B2 (ja) 2024-08-02
HUE061155T2 (hu) 2023-05-28
EP3573631B1 (fr) 2022-11-16
IL268237A (en) 2019-09-26
KR20190130563A (ko) 2019-11-22
PT3573631T (pt) 2023-01-24
ES2937965T3 (es) 2023-04-03
CA3051807C (fr) 2023-07-11
HRP20230122T1 (hr) 2023-03-31
JP2020506183A (ja) 2020-02-27
CN110520141A (zh) 2019-11-29
FI3573631T3 (fi) 2023-03-02
RS63978B1 (sr) 2023-03-31
WO2018138251A1 (fr) 2018-08-02
IL268237B (en) 2022-07-01
FR3062063A1 (fr) 2018-07-27
EP3573631A1 (fr) 2019-12-04
US20200188450A1 (en) 2020-06-18
PL3573631T3 (pl) 2023-05-02
AU2018212530B2 (en) 2022-06-23

Similar Documents

Publication Publication Date Title
AU2016252209B2 (en) Method of preparing a faecal microbiota sample
KR102341203B1 (ko) 분변 미생물총의 샘플의 동결건조 방법
US20250064865A1 (en) Fecal microbiota composition for use in reducing treatment-induced inflammation
JP7527109B2 (ja) 造血幹細胞移植を受けている患者を治療するための便細菌叢
CN104918624A (zh) 恢复排泄物微生物群的组合物及其制造和使用方法
AU2019229721A1 (en) Stool collection method and sample preparation method for transplanting fecal microbiota
US20200038459A1 (en) Composition comprising fecal microbiota
Löwenberg et al. Transplantation of non‐purified autologous bone marrow in patients with AML in first remission
Van Bekkum et al. The effect of pretreatment of allogeneic bone marrow graft recipients with antilymphocytic serum on the acute graft-versus-host reaction in monkeys
Zhang et al. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia.
CN115317518A (zh) 一种肠道微生物增强调节性b细胞对心脏移植排斥反应治疗作用的方法
CN114164112A (zh) 一种微生物保护组合物及其制备方法和应用
WO2021130182A1 (en) Capsule comprising a faecal composition
Cameron et al. Cryopreserved mobilized autologous blood progenitors stored for more than 2 years successfully support blood count recovery after high-dose chemotherapy
Lehn et al. Bone marrow transplantation for chronic granulocytic leukemia
JP2010509360A (ja) 幹細胞移植を補助するためにＡＬＤＨｂｒ細胞を使用する方法
Hirayama et al. Comparison between bacterial growth in platelets (PLTs) washed with M-sol and that in PLT-rich plasma.
Sinitsyn et al. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization
CN121014615A (zh) 一种经血保存液及经血来源间充质干细胞冻存方法
Wolff Autologous bone marrow transplantation—potential usefulness in lung cancer management
Sung et al. Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center
Wingard Past, Present, Future
Schneiderman et al. 222: Donor Chimerism Kinetics in Pediatric Patients Undergoing Reduced Intensity Conditioning (RIC) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Kennedy-Nasser et al. 223: Alternative Donor Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia Using Campath in a Myeloablative Conditioning Regimen

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 4